New UBS rules: what are they and how will they impact Swiss bank?

The Swiss government proposed stricter UBS capital rules that would require systemically important banks to fully back foreign subsidiaries with CET1 capital, up from 60%, implying about a $20 billion increase in UBS's CET1 requirement. UBS would get a seven-year transition period if there are no delays, while software and deferred tax assets would not require full capital backing and AT1 rules were left unchanged for now. The measures could lift UBS's pro forma CET1 ratio to 15.5%, but implementation could be delayed by parliamentary debate and possibly a 2028 referendum.

Analysis

This is a slow-burn de-rating event rather than an immediate earnings shock. The key second-order effect is not the absolute capital increase, but the higher probability that UBS’s equity will continue to trade at a persistent regulatory discount versus global peers because the market now has a clearer path to structurally trapped capital and lower ROE normalization. That matters because UBS has been one of the few European banks where the equity story relied on multiple expansion more than near-term balance sheet growth.

The competitive winners are not necessarily the named peers in the article, but other global wealth and asset-gathering franchises with less domestic political overhang. If UBS is forced to hold meaningfully more capital against foreign subs, management will have less flexibility to optimize capital returns across jurisdictions, which could slow buybacks and force a more conservative posture on growth, M&A, and risk-weighted asset deployment. Over a 6-18 month horizon, that can create a relative valuation gap versus MS and GS, whose capital narratives are more stable and less hostage to referendum risk.

The main contrarian point is that the market may be over-anticipating the near-term equity hit. A seven-year transition dilutes the immediate P&L impact, and the Swiss process itself creates a long optionality window where the final outcome can still be watered down. The real catalyst is not the draft itself but any sign of parliamentary softening, delay, or a referendum path that pushes implementation into 2028+, which would compress the discount quickly.

Tail risk cuts both ways: if the political process hardens, UBS could face a permanent rerating lower because investors will start applying a higher cost of equity to all future capital-light business lines, especially wealth management. Conversely, if risk assets stay firm and UBS continues to generate strong capital, management may be able to absorb the change with less disruption than headlines imply, making the initial selloff an opportunity rather than a thesis break.

Key Decisions for Investors

• Short UBS vs long MS in a 3-9 month pair trade: express the view that UBS deserves a higher regulatory discount and slower capital return trajectory, while MS offers cleaner capital stability and better multiple defense.
• Buy UBS downside via medium-dated puts or put spreads into parliamentary debate season this summer: the best risk/reward is on policy headlines, not on the seven-year implementation path, with a favorable convexity setup if the proposal hardens.
• Fade any sharp post-headline selloff in UBS only after confirmation of diluted legislation: if UBS underperforms by >5-7% on the news, wait for legislative clarity before adding long exposure; the immediate move is likely to be sentiment-driven rather than fundamentals-driven.
• Long HSBC or GS versus UBS on a 6-12 month horizon: both should benefit from relative capital predictability and less headline beta from domestic regulatory intervention.
• Set a tactical alert for referendum risk in 2028: if the political process slips toward a public vote, expect a renewed de-rating of UBS and consider adding to the short on strength rather than weakness.